Boston Scientific (NYSE:BSX) will no longer be acquiring a majority stake in Korea-based medical device manufacturer M.I. Tech. The Marlborough, Massachusetts-based company announced plans to acquire a 64% stake in M.I. Tech in June 2022. It valued the deal at approximately $230 million. At the time, the company expected to close the transaction by the end […]
Men's Health
UroMems picks up FDA STeP designation for smart implant that treats urinary incontinence
UroMems announced that it received Safer Technologies Program (STeP) designation from the FDA for its UroActive smart continence therapy. STeP, a collaborative program, helps reduce the time needed to develop and obtain marketing authorization for eligible devices. FDA launched STeP in 2021, modeling the program on its breakthrough devices designation program. STeP covers devices that […]
Teleflex announces new positive research for UroLift system
Teleflex (NYSE:TFX) today announced new research from multiple studies supporting the prostatic urethral lift (PUL) procedure with its UroLift system. Wayne, Pennsylvania-based Teleflex designed UroLift to treat men with benign prostatic hyperplasia (BPH). It presented data at the 38th Annual European Association of Urology (EAU) Congress in Milan, Italy. The company said in a news […]
Interventional Systems announces endourology venture with surgical robot tech
Interventional Systems announced a new venture — called LARC Robotics — aimed at using surgical robotics for percutaneous renal access. Austria-based Interventional Systems said the unit simplifies percutaneous renal access in percutaneous nephrolithotomy (PCNL) procedures. This minimally invasive surgical technique helps to manage kidney stones. The company said in a news release that Dr. Udo […]
Minerva Surgical closes $30M financing, has new controlling stockholder
Minerva Surgical (Nasdaq:UTRS) announced today that it closed a private placement worth approximately $30 million. Santa Clara, California-based Minerva sold more than 146.6 million shares of its common stock at $0.0246 per share. Accelmed Partners led the private placement with participation by New Enterprise Associates. The financing makes Accelmed the controlling stockholder of Minerva Surgical. […]
J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform
Ethicon, a Johnson & Johnson MedTech company, today announced the first robotic-assisted removal of kidney stones using the Monarch platform. Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022. The University of California, Irvine’s UCI Health used the Monarch platform for urology to complete the first procedure. According […]
FDA clears single-use ureteroscope system from Boston Scientific
Boston Scientific (NYSE:BSX) announced today that it received FDA 510(k) clearance for its LithoVue Elite single-use ureteroscope system. Marlborough, Massachusetts-based Boston Scientific plans a limited U.S. launch for the digital, flexible ureteroscope system in the coming weeks. The company said in a news release that it’s the first ureteroscope system that can monitor intrarenal pressure […]
FDA approves fourth-gen rechargeable sacral neuromod tech from Axonics
Axonics (Nasdaq:AXNX) announced today that the FDA approved its fourth-generation R20 rechargeable sacral neuromodulation system. The implantable system provides therapy for patients suffering from overactive bladder or fecal incontinence. The approval indicates the Axonics R20 for a functional life in the body of at least 20 years. It also reduces the frequency with which a […]
Cook Medical launches urological bipolar electrodes porfolio
Cook Medical announced today that it has launched a streamlined portfolio of urological bipolar electrodes in the U.S. The electrodes are for daily use in bladder and prostate procedures. The new portfolio includes seven products. Six have configurations for use in transurethral resection, ablation and soft tissue removal of the prostate and bladder, and where […]
Minerva Surgical CEO retires, former Activ Surgical head Todd Usen named as replacement
Minerva Surgical (Nasdaq:UTRS) announced that it appointed Todd Usen to replace retiring President and CEO David Clapper. Clapper served as president and CEO of the abnormal uterine bleeding (AUB) treatment developer since 2011. Minerva selected Former Activ Surgical CEO Todd Usen to take over those roles and become a member of the board, effective Jan. […]
Medtronic enrolls first patients in Hugo surgical robot clinical trial
Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot. Dr. Michael R. Abern at Duke University Hospital (Durham, North Carolina) performed the procedure. He used the Hugo robotic-assisted surgery (RAS) system for a robotic-assisted prostatectomy procedure. “This is an exciting moment,” said Abern. […]